Recommended
|
June 23 - 26
San Diego
________________
|
Cut the Cost of Shipping Services
|
Join the SoCalBio Group Purchasing Program to enjoy significant savings on FedEx Shipments

Click here to learn more
For more info, call SoCalBio at
800-418-7079 ext 3
|
Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth.
|  |
Thanks to SoCalBio Media Partners
|
|
|
New Funding |
Los Angeles-Based Biotech C3 Jian Raises $60 Million
Led by Todd Patrick, C3 Jian is developing biopharmaceuticals aimed at improving oral healthcare. The company announced that it has raised $60.5M in a Series D financing. The funding was led by Renaissance Holding Company, and also included affiliates of Delta Dental. According to the company's release, the funds will go towards clinical development of the company's peptide-based, antimicrobial drugs, which are aimed at attacking Streptococcus mutans, a bacterium responsible for dental caries or tooth decay ... Read more
|
Patenting |
Claremont BioSolutions Announces Issue of Key Patent Covering its DNA Sample Preparation Technology
Claremont BioSolutions CEO Gary Blackburn commented that "it is rewarding to see the patent office validate the novelty of this technology; we expect to use these devices in collaborations with diagnostics companies that want to incorporate a reliable, rapid, and inexpensive sample prep technology into point-of-care (POC) consumable cartridges." .... Read more
|
Register Now
|
April 1st, 2 - 4 pm, at SoCalBio's Office in Downtown Los Angeles: Doing Business in Thailand
(SoCalBio members and invited guests)

April 3, 4 to 7 pm, at UCI Calit2 Auditorium (Irvine): SoCalBio Business Mixer: Equity Crowdfundig (open to the public)
April 17, 11 am to 2 pm, at Biolase Inc. (Irvine)
SoCalBio Executive Luncheon: Patent Reform (SoCalBio members and invited guests)
May 15, 8 am to 4 pm, at Calit2 Auditorium in Irvine: SoCalBio Workshop: Accessing Government Grant Funding (open to the public)
|
Make Your Voice Heard in DC
|
Join SoCalBio at the BIO Legislative Day in Washington, D.C. on April 8 and 9
Join SoCalBio's team and other biotechnology executives from across the country who will go to D.C. for a day and a half of legislative briefings and advocacy on Capitol Hill. This fly-in is organized by the Biotechnology Industry Organization to give you the opportunity to meet with your congressional representative and other legislators to educate them about the importance of the biotech industry for job and wealth creation.
Contact SoCalBio, if you are a bioscience industry executive interested in participation and located in Los Angeles, Orange County, the Inland Empire and the communities of the Gold Coast of Ventura and Santa Barbara. Send email to: scbc@socalbio.org
|
Meet New SoCalBio Members |
Biolase Inc. (Irvine)
Biolase specialize in the development, manufacturing and marketing of lasers and related products to provide biological treatments that eliminate pain and are safer for patients .. Learn more
ADRx (Thousand Oaks)
ADRx, Inc. is a biopharmaceutical company created to develop first-in-class and best-in-class drugs for amyloid diseases. The company intends to discover and develop drug candidates independently and in partnertnership with pharmaceutical and biotechnology companies ...
Biotechnical Services Inc. (San Diego)
Provides scientific lab equipment sales and services, such as calibration and validation.... Learn more
Response Genetics (Los Angeles)
Response Genetics is a publicly traded biotech company focused on developing molecular diagnostic assays to help determine the patient's response to cancer therapies ... Learn More
Pharmacos Biopharmaceutical Services (Irvine)
Pharmacos services small to mid-size specialty biopharmaceutical and medical device companies by providing a complete suite of outsourcing and/or consulting services which support drug development, registration, commercialization, life cycle management and commercial operations ..
CRB USA (Carlsbad)
CRB is a global design, construction and consulting firm that services the bioscience and other advanced technology industries. The firm employs over 600 people in 10 offices serving clients throughout the world ... Learn More
|
Recommended Event
|
Celebrate Medical Innovation at LA BioMed
Thursday, April 24, 2014 from -- 12:30 PM to 5:30 PM
Free for SoCalBio Members
|
Digital Health
|
In an Interview with Larry King, Patrick Soon-Shiong Announced He Is Developing Affordable Hearing Aids Using Smart Phone Apps
 | Click on Image to Watch Video Clip |
|
Emerging Markets
|
China Bans Genetic Testing
Genetic Engineering News reports that "the China Food and Drug Administration posted a new regulation that immediately banned genetic testing-even previously approved services "including prenatal genetic testing, gene sequencing technology-related products, and cutting-edge products and technologies." The far-ranging ban applies to "all medical technology applications requiring detection equipment, medical diagnostic reagents, and related software; and other products, such as for disease prevention, diagnosis, care, treatment, monitoring, health status evaluation, and prediction of genetic diseases," according to a translation of the directive via Google Translate. ... Read more
|
Honors
|
Los Angeles-Based Second Sight Listed Among MIT's 2014 Fifty Smartest Companies in the World
MIT Technology Review's list of the "50 Smartest Companies 2014" features quite a few medical device and healthcare technology innovators. The list, compiled by the magazine's editors, is meant to "highlight companies that have displayed impressive innovations in the past year. It is not based on quantitative measures such as patents or R&D spending." Second Sight Medical Products is listed as number 20 because of its success in bringing to market a retinal implant that reverses blindness in patients suffering from retinitis pigmentosa .. See the list
West Los Angeles-Based Neutrogena Honors
CRB Builders
CRB has provided general construction services at Neutrogena's fully operational commercial product and OTC facility consistently since 2011. The award recognizes the CRB team for performing all construction activities on site with zero incidents. Furthermore, the team received zero EHS&S observations of potential safety concerns-going above and beyond the safety requirements and leading by example ... Read more
|
M&As
|
Irvine-Based Aubrey Group Acquired by Sparton
Aubrey Group is a design and manufacturing company using state-of-the-art technologies to develop new products for OEMs in the Medical and Biotechnological markets. Inventors, entrepreneurs, and industry leading OEMs utilize Aubrey Group's design and engineering teams to develop innovative solutions in a timely manner, delivering its clients' new products into the marketplace faster and more cost effectively. .. Read press release
|
Melanoma |
Amgen's Talimogene Laherparepvec Reduced Size Of Melanoma Tumors In New Phase 3 Retrospective Analysis
 Talimogene laherparepvec (T-vec) is an investigational oncolytic immunotherapy designed to selectively replicate in tumor tissue and to initiate a systemic anti-tumor immune response. Amgen said in a recent release that T-vec "reduced the size of injected tumors and also non-injected tumors that had metastasized to other parts of the body. The analysis recorded tumor-level responses from a pivotal Phase 3 study evaluating talimogene laherparepvec in patients with injectable unresected stage IIIB, IIIC or IV melanoma compared to granulocyte-macrophage colony-stimulating factor (GM-CSF)" .... Read more
|
Cholesterol Reduction
|
Amgen Announces Positive Top-Line Results From Phase 3 TESLA Trial Of Evolocumab (AMG 145) In Patients With Homozygous Familial Hypercholesterolemia
Amgen said its monoclonal antibody - evolocumab -- met its primary endpoint of the percent reduction from baseline at week 12 in low-density lipoprotein cholesterol (LDL-C). The percent reduction in LDL-C, or "bad" cholesterol, was clinically meaningful and statistically significant. Evolocumab is an investigational fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that reduces the liver's ability to remove LDL-C from the blood.. Read more
|
Moving up
|
Amgen Names David Piacquad Senior Vice President, Business Development
According to Amgen's press release, Piacquad (photo right) "will report directly to Robert A. Bradway, chairman and chief executive officer, and will be responsible for business development across Amgen. Piacquad leads a new organization that combines the previously separate Corporate Development and External Research & Development groups" ... Read more
|
Jobs ... Jobs ... jobs |
C3 Jian (Los Angeles)
Second Sight Medical Products (Sylmar)
Bruin Biometrics (Los Angeles)
Chromologic (Pasadena)
- Senior Hardware Engineer - Machine Vision Systems
- Sr. Scientist - Optics
- Sr. Scientist - Biomedical Engineering
- Senior Applications Engineer
- Senior Applications Engineer - Biomedical
- Principal Research Scientist - Biologics
Gilead (San Dimas)
Gilead (Oceanside)
Biolase (Irvine)
Xencor (Monrovia)
Aubery Group (Irvine)
|
|
About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
Join SoCalBio |

|
|
|